Mark K. White - 07 Jul 2021 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director
Signature
/s/ Jeffrey McGroarty, Attorney-in-Fact for Mark White
Issuer symbol
ANVS
Transactions as of
07 Jul 2021
Net transactions value
$0
Form type
4
Filing time
09 Jul 2021, 18:28:56 UTC
Next filing
13 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANVS Stock Option (right to buy) Award $0 +4,000 $0.000000 4,000 07 Jul 2021 Common Stock 4,000 $102.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to serve as a director of the issuer on the applicable vesting date.